382 related articles for article (PubMed ID: 8844798)
1. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
[TBL] [Abstract][Full Text] [Related]
2. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
Chou HC; Lang NP; Kadlubar FF
Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
[TBL] [Abstract][Full Text] [Related]
4. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
5. Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation.
Kim KH; Isin EM; Yun CH; Kim DH; Guengerich FP
FEBS J; 2006 May; 273(10):2223-31. PubMed ID: 16649998
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
Josephy PD; Evans DH; Parikh A; Guengerich FP
Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
[TBL] [Abstract][Full Text] [Related]
7. Relationship between content and activity of cytochrome P450 and induction of heterocyclic amine DNA adducts in human liver samples in vivo and in vitro.
Baranczewski P; Möller L
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1071-8. PubMed ID: 15184267
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 activation of arylamines and heterocyclic amines.
Kim D; Guengerich FP
Annu Rev Pharmacol Toxicol; 2005; 45():27-49. PubMed ID: 15822170
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic studies of the activation of heterocyclic food mutagens in man.
Boobis AR; Gooderham NJ; Rich KJ; Zhao K; Edwards RJ; Murray BP; Lynch AM; Murray S; Davies DS
Princess Takamatsu Symp; 1995; 23():134-44. PubMed ID: 8844804
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates.
Kato R
Crit Rev Toxicol; 1986; 16(4):307-48. PubMed ID: 3519087
[TBL] [Abstract][Full Text] [Related]
11. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
Kim D; Guengerich FP
Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and biodisposition of heterocyclic amines.
Turesky RJ
Prog Clin Biol Res; 1990; 347():39-53. PubMed ID: 2217401
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes.
Hammons GJ; Milton D; Stepps K; Guengerich FP; Tukey RH; Kadlubar FF
Carcinogenesis; 1997 Apr; 18(4):851-4. PubMed ID: 9111224
[TBL] [Abstract][Full Text] [Related]
15. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes.
Yamazaki H; Shaw PM; Guengerich FP; Shimada T
Chem Res Toxicol; 1998 Jun; 11(6):659-65. PubMed ID: 9625734
[TBL] [Abstract][Full Text] [Related]
16. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada T; Hayes CL; Yamazaki H; Amin S; Hecht SS; Guengerich FP; Sutter TR
Cancer Res; 1996 Jul; 56(13):2979-84. PubMed ID: 8674051
[TBL] [Abstract][Full Text] [Related]
17. Interactions of procarcinogenic heterocyclic amines and indolocarbazoles with the dioxin receptor.
Kleman M; Gustafsson JA
Biol Chem; 1996 Nov; 377(11):741-62. PubMed ID: 8960375
[TBL] [Abstract][Full Text] [Related]
18. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
Parikh A; Josephy PD; Guengerich FP
Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
[TBL] [Abstract][Full Text] [Related]
20. Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl.
Yun CH; Hammons GJ; Jones G; Martin MV; Hopkins NE; Alworth WL; Guengerich FP
Biochemistry; 1992 Nov; 31(43):10556-63. PubMed ID: 1420171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
